$Advanced Micro Devices (AMD.US)$
$AMD plans $1.9 billion acquisition of Pensando Systems.

$Tesla (TSLA.US)$
Guys.. advise please..

SpaceX said on Tuesday its partially reusable Falcon 9 rocket has completed the thirty-first and the final launch of this year, marking the twenty-fourth resupply mission to the International Space Station (ISS).
What Happened: $Tesla (TSLA.US)$ CEO Elon Musk-led company’s Falcon 9 rocket — a two-stage, heavy-lift launch vehicle — has returned to earth after sending the Dragon cargo ship toward the ISS.
The launch was broadcast live and the development was confirmed by NASA and SpaceX.
The ISS, weighing more than 6,500 pounds with the supplies, is expected to dock itself to the space station about 24 hours after the launch.
The Falcon 9 rocket took off at 5.07 a.m. ET on Tuesday from NASA’s Kennedy Space Center.
The space company run by the billionaire entrepreneur had last year completed 26 missions and 21 launches in 2019.
The latest launch comes after back-to-back two launches over the weekend. The Falcon 9 first launched the company’s Starlink 52 internet satellites to orbit, designated the Group 4-4 mission. It later deployed Turkey's new telecommunication satellite.
Falcon 9 has been regularly launching since at least early 2018 now. Musk marveled at the feat from inception.
Why It Matters: Musk founded SpaceX with the mission to make humanity multi-planetary. He has in the past said he remains “highly confident” that SpaceX would land humans on Mars by 2026.
The Starship would eventually replace Falcon 9, Falcon Heavy, and Dragon 2 rockets and be able to carry much more mass into orbit.
The ambitious transportation system can also carry humanity to the moon, Mars and make interplanetary travel possible.
The Starship system was selected in April to assist NASA with its Artemis moon-landing program.

$Tesla (TSLA.US)$CEO, Car Win Accolades, Doge Payment Mooted, And More: The week brought in a double delight for Musk, who was named by both the Time magazine and the Financial Times as their respective "Person of the Year." Musk's products also came out on top, with Tesla's Model 3 vehicle winning Edmund's top-rated EV badge. In other noteworthy Tesla news, Musk announced on Twitter that Tesla will try out Dogecoin payments for some merchandise. He also released another video tour of Tesla's Giga Shanghai. Musk continued to offload Tesla shares, while Tesla bull Cathie Wood's Ark Invest also extended its Tesla selling.
$Rivian Automotive (RIVN.US)$Forecasts Production Shortfall In 2021: Rivian disappointed with its first quarterly report as a public company, with the EV maker warning of production shortfalls in 2021. Sell-side, however, did not attach too much significance to the negative catalyst and instead chose to focus on the long term.
General Motors Teases GMC Sierra: $General Motors (GM.US)$, which has embarked on a journey toward electrification, teased an EV version of its GMC Sierra pickup truck. The teaser image showed only the front end of the vehicle. The EV is likely to be pitched against Rivian's R1T, $Ford Motor (F.US)$ F-150 Lightning and Tesla's Cybertruck.
Ford Means Business: $Ford Motor (F.US)$ CEO Jim Farley said in an interview to Bloomberg this week that the company hopes to produce 600,000 EVs per year in two years. Farley also hinted at the prospect of the company overtaking market leader Tesla.
Plug Power Inks Hydrogen Fuel Cell System to Edison Motors: $Plug Power (PLUG.US)$ and South Korea's Edison Motors signed on the dotted line for the mass launch of hydrogen-powered EV buses, first in the South Korean and eventually to overseas markets.
Lucid to Join Nasdaq-100 Index: The news of $Lucid Group (LCID.US)$ inclusion in the Nasdaq-100 Index proved salubrious to this Tesla killer.

$Amazon (AMZN.US)$ India's antitrust agency on Friday suspended Amazon.com's 2019 deal with Future Group, potentially denting the U.S. company's attempts to block the sale of Future's retail assets to an Indian peer.
The regulator ruled that the U.S. e-commerce group had suppressed information while seeking regulatory approval on an investment into Indian retailer Future Group two years ago.
The ruling by the Competition Commission of India (CCI) could have far-reaching consequences for Amazon's legal battles with now estranged partner Future.
Amazon has for months successfully used the terms of its toehold $200 million investment in Future in 2019 to block the Indian retailer's attempt to sell retail assets to Reliance Industries for $3.4 billion.
The regulator's 57-page order said it considers "it necessary to examine the combination (deal) afresh," adding its approval from 2019 "shall remain in abeyance" until then.
The CCI's order said Amazon had "suppressed the actual scope" of the deal and had made "false and incorrect statements" while seeking approvals. The CCI order imposed a penalty of around 2 billion rupees ($27 million) on the U.S. company.

$Tesla (TSLA.US)$ don't underestimate growth stocks/momentum stocks ...work from home and tech will be the standard durring pandemic... $Apple (AAPL.US)$ $DocuSign (DOCU.US)$ $Zoom Video Communications (ZM.US)$ $PayPal (PYPL.US)$

$Tesla (TSLA.US)$ RIP to my calls & Merry Christmas 🎄💂🏿‍♂️💰 to my couple puts

$GameStop (GME.US)$ GameStop (GME) – The videogame retailer – one of the so-called “meme” stocks – lost another 3.1% in the premarket following a nearly 14% tumble yesterday to its lowest close since March. GameStop had seen its stock slide last week after reporting a wider quarterly loss.
$AMC Entertainment (AMC.US)$ AMC Entertainment (AMC) – The movie theater operator’s stock slid 6% in premarket trading, after extending a losing streak to 3 days with a more than 15% plummet Monday. Last week, CEO Adam Aron sold all his holdings in AMC while CFO Sean Goodman sold the bulk of his AMC stock.
$Pfizer (PFE.US)$ Pfizer (PFE) – The drugmaker said a final study of its antiviral Covid-19 pill showed it to be 89% effective in preventing hospitalizations and deaths in high-risk patients, similar to what earlier studies had shown. It added that the drug appears to be effective against the omicron variant.